home / stock / fprx / fprx quote
Last: | $38 |
---|---|
Change Percent: | 0.03% |
Open: | $37.99 |
Close: | $38 |
High: | $38.01 |
Low: | $37.95 |
Volume: | 968,246 |
Last Trade Date Time: | 04/15/2021 04:56:59 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$38 | $37.99 | $38 | $38.01 | $37.95 | 968,246 | 04-15-2021 |
$37.99 | $37.96 | $37.99 | $37.99 | $37.94 | 838,965 | 04-14-2021 |
$37.94 | $37.96 | $37.94 | $37.98 | $37.94 | 943,653 | 04-13-2021 |
$37.97 | $37.91 | $37.97 | $37.97 | $37.91 | 694,382 | 04-12-2021 |
$37.94 | $37.91 | $37.94 | $37.96 | $37.9 | 652,429 | 04-09-2021 |
$37.89 | $37.92 | $37.89 | $37.95 | $37.89 | 1,553,877 | 04-08-2021 |
$37.92 | $37.92 | $37.92 | $37.97 | $37.9 | 1,403,395 | 04-07-2021 |
$37.98 | $37.95 | $37.98 | $37.98 | $37.91 | 2,221,050 | 04-06-2021 |
$37.65 | $37.82 | $37.65 | $37.9 | $37.6 | 1,361,361 | 04-05-2021 |
$37.81 | $37.79 | $37.81 | $37.82 | $37.695 | 1,512,846 | 04-02-2021 |
$37.81 | $37.79 | $37.81 | $37.82 | $37.695 | 1,512,707 | 04-01-2021 |
$37.67 | $37.77 | $37.67 | $37.88 | $37.67 | 2,434,459 | 03-31-2021 |
$37.74 | $37.74 | $37.74 | $37.78 | $37.72 | 1,417,142 | 03-30-2021 |
$37.72 | $37.85 | $37.72 | $37.85 | $37.72 | 1,296,324 | 03-29-2021 |
$37.9 | $37.76 | $37.9 | $37.9 | $37.72 | 1,491,998 | 03-26-2021 |
$37.79 | $37.75 | $37.79 | $37.9 | $37.71 | 2,088,727 | 03-25-2021 |
$37.72 | $37.8 | $37.72 | $37.85 | $37.71 | 1,743,611 | 03-24-2021 |
$37.72 | $37.74 | $37.72 | $37.83 | $37.715 | 1,118,997 | 03-23-2021 |
$37.75 | $37.9 | $37.75 | $37.9 | $37.7 | 1,104,291 | 03-22-2021 |
$37.92 | $37.7 | $37.92 | $38 | $37.65 | 3,491,548 | 03-19-2021 |
News, Short Squeeze, Breakout and More Instantly...
Five Prime Therapeutics Inc. Company Name:
FPRX Stock Symbol:
NASDAQ Market:
Five Prime Therapeutics Inc. Website:
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics PR Newswire THOUSAND OAKS, Calif. , April 16, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all out...
Amgen (NASDAQ: AMGN) recently announced plans to acquire Five Prime Therapeutics (NASDAQ: FPRX) for approximately $1.9 billion. The deal gives Amgen rights to bemarituzumab, which has made it through phase 2 testing. In this video from Motley Fool Live , recorded on ...
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) announced today that it has canceled its fourth quarter and full year 2020 earnings conference call, which was previously scheduled for Wednesday, March 10, 2021 at 1:30 p.m. PT / 4:30 p.m. ET. The cancellation is the result of the co...